Welcome to our dedicated page for Azenta news (Ticker: AZTA), a resource for investors and traders seeking the latest updates and insights on Azenta stock.
Azenta, Inc. provides life sciences solutions focused on cold-chain sample management, automated storage, consumables, informatics, repository services and multiomics offerings. Its updates commonly cover the Sample Management Solutions and Multiomics businesses, including genomic services, gene synthesis execution, sample storage, high-throughput processing and branded products such as GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro and Barkey.
Azenta news also includes quarterly operating results, guidance updates, long-range planning, governance and leadership changes, customer and research partnerships, and acquisition activity. The completed acquisition of UK Biocentre expanded the company’s sample management, sample storage and processing capabilities in the United Kingdom and added a European operational hub for its Sample Repository Services business.
Azenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2024 earnings on May 8, 2024, after market close. The Company will hold a conference call and webcast to discuss financial results the same day at 4:30 p.m. Eastern Time. Analysts, investors, and media can access the live webcast on the Azenta website.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.